Key pathways in Ebola infection identifiedJune 24th, 2009 - 5:20 pm ICT by ANI
Washington, June 24 (ANI): Scientists have identified two biochemical pathways-PI3 kinase pathway and the CAMK2 pathway-that are vital for Ebola virus infection.
For the study, the researchers the University of Texas Medical Branch at Galveston used substances that block the activation of those pathways, and prevented Ebola infection in cell culture experiments.
In this way they potentially offered a critical early step in developing the first successful therapy for the deadly virus.
Ebola inflicts severe and often fatal hemorrhagic fever on its victims, producing 90 percent mortality rates in some outbreaks, but to date no vaccine exists for the virus, and it is considered a high-risk agent for bioterrorism.
Robert Davey, lead author of the study, said that they took a new approach to stopping viral infection, using powerful new computational and analytical techniques to focus more on the host cell than the virus.
“The premise for this work is that the virus is essentially nothing without a cell. It needs to rely on many cell proteins and factors for it to replicate. The idea is that if we can suppress the expression of those cell proteins for just a short time, we can then stop the disease in its tracks,” he said.
For spotting the critical proteins, the researchers first conducted large-scale screening experiments using sets of cells treated with small interfering RNA (siRNA) to block 735 different genes that might produce proteins important to Ebola infection.
Later, they added Ebola “pseudotype” viruses-artificially created virus particles made by wrapping Ebola envelope proteins around a core of genetic material from another virus.
“We got a number of hits, quite a lot of places where the virus wasn’t infecting the cells. The problem was then to understand what those hits meant,” said Davey.
To reach a conclusion, the researchers turned to a newly developed statistical algorithm designed especially to prioritise the results of siRNA screens.
After subjecting that output to further computational analysis, they found that two networks of biochemical reactions seemed particularly important to Ebola’s entry into cells: The PI3 kinase pathway and the CAMK2 pathway.
The above accomplishment could lead to first therapy for deadly disease. (ANI)
- Molecule engineered to attack HIV shows positive results - Jan 20, 2011
- Successful Ebola cure in monkeys offers hope to humans - Jun 10, 2010
- Interfering genes protect monkeys from lethal Ebola virus post-exposure - May 30, 2010
- New discovery may offer treatment for hemorrhagic fever - Sep 04, 2008
- Cellular protein that acts as receptor for Ebola virus identified - May 03, 2011
- Scientists uncover chink in Ebola cell-invasion strategy - Sep 04, 2008
- How H1N1 virus infects body - Dec 22, 2009
- New process to 'program' cancer cell death created - Sep 08, 2010
- Gene-silencing that could prevent diabetes-related heart failure - Dec 10, 2010
- Measles virus is 'the latest weapon against cancer' - Jan 13, 2011
- New discovery may help in the fight against Ebola infection - Jan 20, 2011
- Adopting 'synthetic lethality' could boost molecularly targeted cancer therapy - Sep 22, 2010
- Gene therapy to brain may treat major depression - Oct 21, 2010
- 'Good cholesterol' nanoparticles may help fight cancer - Apr 02, 2011
- New experimental drug slows down growth of ovarian cancer - Apr 16, 2011
Tags: analytical techniques, biochemical pathways, cell proteins, critical proteins, deadly virus, ebola, hemorrhagic fever, host cell, mortality rates, risk agent, robert davey, sirna, small interfering rna, statistical algorithm, texas medical branch, university of texas medical branch, university of texas medical branch at galveston, virus ebola, virus infection, virus particles